Towards Understanding How Social Factors Shaped a Behavioral Intervention on Healthier Infant Formula-Feeding
Qualitative Health Research
Reason for embargo
Currently under an indefinite embargo pending publication by SAGE Publications. No embargo required on publication.
As part of a process evaluation, we explored in semi-structured interviews the experiences of nineteen mothers who had taken part in a trial to reduce infant formula-milk intake and promote healthy weight gain, and reflections of three facilitators who delivered the intervention and control group protocols. Mothers appreciated the non-judgmental support provided during the trial, after experiencing stigma and receiving limited advice on how, how much and how often formula-milk should be given. The information mothers had previously found, printed on formula-milk tins, or provided by family, friends and health professionals, was often perceived as contradictory; the trial guidance also conflicted with social norms relating infant health positively with weight gain. For those recruited into the trial with older infants, who had already exceeded the recommendations, reducing formula-milk amounts was difficult. The findings highlight the difficulties of addressing a highly stigmatized, complex social practice with an individual, behavioral intervention approach.
The Baby Milk trial was funded by the National Prevention Research Initiative (Grant no. MR/J000361/1). The work was undertaken under the auspices of the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence which is funded by the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust. The Funding Partners relevant to this award are (in alphabetical order): Alzheimer’s Research Trust; Alzheimer’s Society; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research UK; Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Health and Social Care Research and Development Division of the Public Health Agency (HSC R&D Division); Medical Research Council; The Stroke Association; Wellcome Trust; Welsh Assembly Government; and World Cancer Research Fund. Rajalakshmi Lakshman was supported by a MRC Population Health Fellowship (Grant no. G070165) and Ken Ong is supported by the MRC (Unit Programme MC_UU_12015/2).
This is the author accepted manuscript.
Awaiting citation and DOI